Spritam

Spritam is the first medicine printed on the 3D-printer. The medicine created by pharmaceutical company Aprecia Pharmaceuticals is intended for patients with epilepsy.

2016: Beginning of sales

On March 22, 2016 in the USA Spritam sales began. This first medicine which is completely printed on the 3D-printer will form a basis for development of new medicines by means of technology of volume printing.

Spritam received the porous structure allowing to dissolve quickly medicine in water that simplifies its acceptance by patients during epileptic spasms. The ZipDose technology developed in the Massachusetts Institute of Technology is involved in medicine.

Spritam is the first medicine printed on the 3D-printer

Having studied potentialities of use of our 3D technology - printing in prescription medicines, we understood importance of convenient administration of drugs at some diseases — the CEO of Aprecia Don Wetherhold says. — Spritam changed a drug intake method at epilepsy and became the first in a line of the products developed by us providing patients and those who look after them, additional methods of treatment.

Spritam is approved by Federal management on supervision of quality food and medicines of the USA (U.S.Food and Drug Administration, FDA) that allowed medicine to appear in mass market. In the American drugstores it is available in the form of tablets with doses of 250, 500, 750 and 1000 mg. The price of medicine is not set.

Aprecia Pharmaceuticals is going to make also other medicines using 3D - printing. It is supposed that they will help to struggle with diseases of the central nervous system, a depression, Parkinson's disease, schizophrenia, etc.^[1]

Notes